ArticlebioRxiv : the preprint server for biology2025
Large Numbers of New Human Paralogs Discovered.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The identification of paralogs is critical for understanding protein evolution, function, and for drug design, yet many human proteins remain unannotated and poorly classified. Sequence-based homology detection alone often fails to detect distant paralogs, especially in the "twilight zone" or beyond, regarding sequence identity. Here we present an integrated homolog detection framework that combines results from BLASTp, MMseqs2, Foldseek, and the large protein language model-based tool PROST, followed by validation based on comparison of structures and for enzymes comparison of the specific structures of the catalytic residues. Using all-versus-all exhaustive comparisons across the 20,647 human proteins, we systematically identify novel paralogs and assess their catalytic residues for two serine protease clans. We discovered 14 previously uncharacterized human serine carboxypeptidases, validated against experimentally determined PDB structures, with 11 of these displaying conserved catalytic triads. We further identify 203 new paralogs for human kinases, with 163 of these in the major clusters that represent previously uncharacterized kinase subtypes and 30 putative novel human transcription factors. Across both serine protease subtypes, structural alignments enable the prediction of the previously unknown catalytic residues for those lacking UniProt annotations of active site residues. By integrating sequence, structure, and LPLM embedding-based approaches, the framework enables the discovery of surprisingly large numbers of unknown paralogs, permitting defining catalytic residues, and expands the understanding of protein functional landscapes. These findings provide the foundation for a large number of future functional, evolutionary, and therapeutic investigations.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.